Search research articles
Contact Us
Filters
Showing results (61-70 of 72) with videos related to
Page
of 8
Sort By:
Thorax
|
February 1, 1987
Impaired tracheobronchial clearance in bronchiectasis
D C Currie, D Pavia, J E Agnew, et al.
The American Journal of Tropical Medicine and Hygiene
|
November 1, 1995
Treatment of porcine cysticercosis with albendazole
A E Gonzalez, H H Garcia, R H Gilman, et al.
Neurology
|
June 1, 1993
Antigen processing gene polymorphisms in HLA-DR2 multiple sclerosis
R Liblau, P M van Endert, M Sandberg-Wollheim, et al.
European Journal of Respiratory Diseases
|
February 1, 1985
Assessment of percussion, vibratory-shaking and breathing exercises in chest physiotherapy
P P Sutton, M T Lopez-Vidriero, D Pavia, et al.
European Journal of Respiratory Diseases
|
January 1, 1983
Assessment of the forced expiration technique, postural drainage and directed coughing in chest physiotherapy
P P Sutton, R A Parker, B A Webber, et al.
Soft Matter
|
March 31, 2017
Effect of particle concentration on the microstructural and macromechanical properties of biocompatible magnetic hydrogels
A B Bonhome-Espinosa, F Campos, I A Rodriguez, et al.
Respiration; International Review of Thoracic Diseases
|
January 1, 1989
Effect of four-week treatment with oxitropium bromide on lung mucociliary clearance in patients with chronic bronchitis or asthma
D Pavia, M T Lopez-Vidriero, J E Agnew, et al.
The American Journal of Tropical Medicine and Hygiene
|
April 1, 1996
Effective, single-dose treatment or porcine cysticercosis with oxfendazole
A E Gonzales, H H Garcia, R H Gilman, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association
|
July 31, 2012
A high oxfendazole dose to control porcine cysticercosis: pharmacokinetics and tissue residue profiles
L Moreno, M T Lopez-Urbina, C Farias, et al.
Annals of the Rheumatic Diseases
|
June 7, 2013
The timing of serum infliximab loss, or the appearance of antibodies to infliximab (ATI), is related with the clinical activity in ATI-positive patients with rheumatoid arthritis treated with infliximab
Ch Plasencia, D Pascual-Salcedo, P Alcocer, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 72) with videos related to
Sort By:
Page
of 8
Thorax
|
February 1, 1987
Impaired tracheobronchial clearance in bronchiectasis
D C Currie, D Pavia, J E Agnew, et al.
The American Journal of Tropical Medicine and Hygiene
|
November 1, 1995
Treatment of porcine cysticercosis with albendazole
A E Gonzalez, H H Garcia, R H Gilman, et al.
Neurology
|
June 1, 1993
Antigen processing gene polymorphisms in HLA-DR2 multiple sclerosis
R Liblau, P M van Endert, M Sandberg-Wollheim, et al.
European Journal of Respiratory Diseases
|
February 1, 1985
Assessment of percussion, vibratory-shaking and breathing exercises in chest physiotherapy
P P Sutton, M T Lopez-Vidriero, D Pavia, et al.
European Journal of Respiratory Diseases
|
January 1, 1983
Assessment of the forced expiration technique, postural drainage and directed coughing in chest physiotherapy
P P Sutton, R A Parker, B A Webber, et al.
Soft Matter
|
March 31, 2017
Effect of particle concentration on the microstructural and macromechanical properties of biocompatible magnetic hydrogels
A B Bonhome-Espinosa, F Campos, I A Rodriguez, et al.
Respiration; International Review of Thoracic Diseases
|
January 1, 1989
Effect of four-week treatment with oxitropium bromide on lung mucociliary clearance in patients with chronic bronchitis or asthma
D Pavia, M T Lopez-Vidriero, J E Agnew, et al.
The American Journal of Tropical Medicine and Hygiene
|
April 1, 1996
Effective, single-dose treatment or porcine cysticercosis with oxfendazole
A E Gonzales, H H Garcia, R H Gilman, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association
|
July 31, 2012
A high oxfendazole dose to control porcine cysticercosis: pharmacokinetics and tissue residue profiles
L Moreno, M T Lopez-Urbina, C Farias, et al.
Annals of the Rheumatic Diseases
|
June 7, 2013
The timing of serum infliximab loss, or the appearance of antibodies to infliximab (ATI), is related with the clinical activity in ATI-positive patients with rheumatoid arthritis treated with infliximab
Ch Plasencia, D Pascual-Salcedo, P Alcocer, et al.
Page
of 8